ConvaTec Group Plc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CNVVF research report →
About the company
ConvaTec Group Plc is a global medical technology company focused on creating, producing, and distributing a wide array of healthcare products. Their offerings span several key areas: Advanced Wound Management: This includes specialized dressings and skincare solutions for treating both acute and chronic wounds, which can arise from conditions like diabetes, prolonged immobility, venous disease, traumatic injuries, burns, or surgical interventions. Ostomy Care: The company provides vital devices, accessories, and support services for individuals who have undergone ostomy procedures, often necessitated by conditions such as colorectal or bladder cancer, inflammatory bowel disease, or obesity.
- CEO
- Jonathan Peter Mason
- IPO
- 2017
- Employees
- 10,489
- HQ
- Reading, GB
Price Chart
- Market Cap
- $5.32B
- P/E
- 34.10
- P/S
- 2.38
- P/B
- 3.84
- EV/EBITDA
- 11.70
- Div Yield
- 2.41%
- Gross Margin
- 55.76%
- Op Margin
- 16.51%
- Net Margin
- 7.17%
- ROE
- 10.53%
- ROIC
- 9.62%
- Revenue
- $2.49B · 8.91%
- Net Income
- $178.89M · -6.09%
- EPS
- $0.09 · -4.95%
- Op Income
- $416.05M
- FCF YoY
- 24.94%
- 52W High
- $3.65
- 52W Low
- $2.30
- 50D MA
- $2.74
- 200D MA
- $3.00
- Beta
- 0.76
- Avg Volume
- 1.89K
Get TickerSpark's AI analysis on CNVVF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our CNVVF coverage
Recent articles, reports, and earnings notes.
No research on CNVVF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CNVVF report →Similar companies
Peers in the same neighborhood.